湖岸生物上涨8.97%，报0.85美元/股，总市值3503.08万美元

Core Viewpoint - Lakeshore Biotech (LSB) has shown a significant stock price increase of 8.97% on August 18, reaching $0.85 per share, with a total market capitalization of $35.03 million [1]. Financial Performance - As of March 31, 2025, Lakeshore Biotech reported total revenue of 615 million RMB, reflecting a year-on-year growth of 7.24% [1]. - The company recorded a net profit attributable to shareholders of -99.98 million RMB, which represents a substantial year-on-year increase of 76.93% [1]. Company Overview - Lakeshore Biotech is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Beijing Yisheng Biotech Co., Ltd. [1]. - Beijing Yisheng Biotech is a global biopharmaceutical company focused on the discovery, development, production, and commercialization of next-generation vaccines and therapeutic biologics for infectious diseases and cancer treatment [1].